Abstract
Cardiac allograft vasculopathy (CAV) is an important cause of graft failure in heart transplant (HTx) recipients. The purpose of this study was to identify the effect of medication regimens (MR) on the development of CAV in pediatric HTx recipients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have